Blog

In a study of 77 adult patients, clinical interviews, self-rating scales, and QbTest, an objective ADHD test measuring attention, impulsivity, and activity,...

QbTest has been announced as one of 11 innovations selected to join the award-winning NHS Innovation Accelerator (NIA) in 2020.At a launch event chaired by ...

The diagnostic process for ADHD is challenging for all involved.

For a long time diagnoses have been based on professional instinct; based on interviews with...

At the end of 2018, the media repeatedly reported on how Ofsted criticized the education and support of children with special educational needs and...

Latest government figures show an increase in the number of children and young people identified as having SEN, for the first time since 2010.

The so-called...

The management of ADHD is highly associated with substantial fiscal burden.

In England and Wales, for example, children with ADHD place a significant cost on...

The landmark AQUA-trial has now been published [1]: the first independent randomised controlled trial (RCT) demonstrating that QbTest can increase the speed...

By harnessing breakthrough facial recognition technology Qbtech, world leaders in objective testing, have made it possible for more Dutch professionals to...

QbCheck is designed to simplify yet improve medical and financial outcomes. As the only FDA cleared and CE marked online ADHD test it utilises breakthrough...

The US Food and Drug Administration (FDA) has cleared the ADHD test - QbCheck - developed by the Swedish company Qbtech to aid in the assessment and evaluation...

Last month, a mother came into the Focus-MD clinic in Mobile, Alabama, with a concern about her eight-year-old son...

A year and a half earlier, the boy had...

The US Food and Drug Administration (FDA) has cleared the neuropsychological test – QbTest – developed by the Swedish company Qbtech to aid in the evaluation...